Hualan Biological Vaccine Inc. (SHE: 301207)

Hualan Biological Vaccine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,262	640.98	600.04	131.56	412.39	278.7
Short-Term Investments	303	373.46	130	-	-	-
Trading Asset Securities	1,266	1,599	1,419	825.82	452.86	221.9
Cash & Short-Term Investments	2,831	2,613	2,149	957.39	865.25	500.6
Cash Growth	11.73%	21.57%	124.50%	10.65%	72.84%	41.81%
Accounts Receivable	1,175	1,990	1,796	1,439	1,530	692.06
Other Receivables	0.74	1.31	0.41	2.15	2.18	3.24
Receivables	1,176	2,412	1,856	1,441	1,532	695.3
Inventory	378.07	173.47	167.16	107.41	45.27	55.79
Other Current Assets	57.83	28.18	20.22	23.31	22.86	10.08
Total Current Assets	4,444	5,227	4,193	2,529	2,465	1,262
Property, Plant & Equipment	1,113	1,176	1,287	1,351	810.97	349.61
Long-Term Investments	1,415	1,296	1,310	356.3	-	-
Other Intangible Assets	19.8	20.13	20.78	21.43	22.08	22.74
Long-Term Deferred Tax Assets	216.47	217.97	208.56	182.9	170.41	87.13
Long-Term Deferred Charges	28.28	27.94	28.69	33.36	19.58	14.04
Other Long-Term Assets	23.47	30.61	27.98	48.93	159.61	58.81
Total Assets	7,259	7,995	7,076	4,523	3,648	1,794
Accounts Payable	106.42	116.76	125.67	185.5	105.46	15.34
Accrued Expenses	794.6	1,155	1,050	929.48	956.07	448.34
Short-Term Debt	300	300.18	300.18	500.44	200	-
Current Portion of Leases	-	-	-	1.03	-	-
Current Income Taxes Payable	-	50.81	9.24	15.99	154.44	37.74
Current Unearned Revenue	14.53	2.67	2.68	1.54	1.89	3.4
Other Current Liabilities	85.13	60.63	49.13	38.19	36.74	26.36
Total Current Liabilities	1,301	1,686	1,537	1,672	1,455	531.18
Long-Term Leases	-	-	-	0.81	-	-
Long-Term Unearned Revenue	29.31	31.42	35.66	39.89	6	-
Long-Term Deferred Tax Liabilities	13.61	15.22	6.41	2.5	0.28	0.7
Total Liabilities	1,344	1,732	1,579	1,715	1,461	531.88
Common Stock	601.03	600.02	400.01	360	360	100
Additional Paid-In Capital	2,940	2,915	3,089	879.79	879.79	-
Retained Earnings	2,413	2,748	2,008	1,568	947.34	1,162
Shareholders' Equity	5,916	6,263	5,497	2,808	2,187	1,262
Total Liabilities & Equity	7,259	7,995	7,076	4,523	3,648	1,794
Total Debt	300	300.18	300.18	502.27	200	-
Net Cash (Debt)	2,531	2,313	1,849	455.12	665.25	500.6
Net Cash Growth	13.31%	25.07%	306.31%	-31.59%	32.89%	41.81%
Net Cash Per Share	4.20	3.84	3.13	0.84	1.23	0.92
Filing Date Shares Outstanding	598.82	600.02	600.02	600.02	600.02	540
Total Common Shares Outstanding	598.82	600.02	600.02	540	540	150
Working Capital	3,143	3,541	2,656	857.07	1,011	730.59
Book Value Per Share	9.88	10.44	9.16	5.20	4.05	8.41
Tangible Book Value	5,896	6,243	5,476	2,787	2,165	1,239
Tangible Book Value Per Share	9.85	10.40	9.13	5.16	4.01	8.26
Buildings	376.55	376.55	376.19	375.5	169.91	168.25
Machinery	1,473	1,472	1,450	1,388	688.28	432
Construction In Progress	4.09	3.23	3.26	-	315.55	79.5

Source: S&P Capital IQ. Standard template. Financial Sources.